Format

Send to

Choose Destination
Nat Rev Endocrinol. 2015 Nov;11(11):653-61. doi: 10.1038/nrendo.2015.163. Epub 2015 Sep 22.

Endocrine disruptors and obesity.

Author information

1
Division of Extramural Research and Training, Population Health Branch, National Institute of Environmental Sciences, PO Box 12233, Research Triangle Park, NC 27709, USA.
2
Division of the National Toxicology Program, National Institute of Environmental Health Sciences/National Institutes of Health, PO Box 12233, Research Triangle Park, NC 27709, USA.

Abstract

The increasing incidence of obesity is a serious global public health challenge. Although the obesity epidemic is largely fueled by poor nutrition and lack of exercise, certain chemicals have been shown to potentially have a role in its aetiology. A substantial body of evidence suggests that a subclass of endocrine-disrupting chemicals (EDCs), which interfere with endocrine signalling, can disrupt hormonally regulated metabolic processes, especially if exposure occurs during early development. These chemicals, so-called 'obesogens' might predispose some individuals to gain weight despite their efforts to limit caloric intake and increase levels of physical activity. This Review discusses the role of EDCs in the obesity epidemic, the latest research on the obesogen concept, epidemiological and experimental findings on obesogens, and their modes of action. The research reviewed here provides knowledge that health scientists can use to inform their research and decision-making processes.

PMID:
26391979
DOI:
10.1038/nrendo.2015.163
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center